Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brunner

Showing results (691-700 of 792) with videos related to

Pageof 80
Sort By:
EMBO Molecular Medicine|March 16, 2021
Psoriatic skin inflammation is promoted by c-Jun/AP-1-dependent CCL2 and IL-23 expression in dendritic cellsPhilipp Novoszel, Martin Holcmann, Gabriel Stulnig, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Blood Advances|September 29, 2021
t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivitySarah B Mueller, Paola Dal Cin, Long P Le, et al.
Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.
Science Immunology|January 23, 2021
Persistence of mature dendritic cells, T<sub>H</sub>2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockadeChristine Bangert, Katharina Rindler, Thomas Krausgruber, et al.
Leukemia Research|April 18, 2025
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantationBrandon J Aubrey, Traci Blonquist, Malgorzata McMasters, et al.
Cancer|July 13, 2019
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admissionSamuel D Slavin, Alyssa Fenech, Amanda L Jankowski, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2018
Early-onset pediatric atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>17/T<sub>H</sub>22-centered inflammation and lipid alterationsPatrick M Brunner, Ariel Israel, Ning Zhang, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitisNatalia Alkon, Frank P Assen, Tamara Arnoldner, et al.
Drug Discovery Today|February 22, 2025
Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunologyElena Peeva, Emma Guttman-Yassky, Yuji Yamaguchi, et al.
Pageof 80

Showing results (691-700 of 792) with videos related to

Sort By:
Pageof 80
EMBO Molecular Medicine|March 16, 2021
Psoriatic skin inflammation is promoted by c-Jun/AP-1-dependent CCL2 and IL-23 expression in dendritic cellsPhilipp Novoszel, Martin Holcmann, Gabriel Stulnig, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Blood Advances|September 29, 2021
t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivitySarah B Mueller, Paola Dal Cin, Long P Le, et al.
Blood Advances|January 7, 2020
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangementValentina Nardi, Nora Ku, Matthew J Frigault, et al.
Science Immunology|January 23, 2021
Persistence of mature dendritic cells, T<sub>H</sub>2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockadeChristine Bangert, Katharina Rindler, Thomas Krausgruber, et al.
Leukemia Research|April 18, 2025
A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantationBrandon J Aubrey, Traci Blonquist, Malgorzata McMasters, et al.
Cancer|July 13, 2019
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admissionSamuel D Slavin, Alyssa Fenech, Amanda L Jankowski, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2018
Early-onset pediatric atopic dermatitis is characterized by T<sub>H</sub>2/T<sub>H</sub>17/T<sub>H</sub>22-centered inflammation and lipid alterationsPatrick M Brunner, Ariel Israel, Ning Zhang, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitisNatalia Alkon, Frank P Assen, Tamara Arnoldner, et al.
Drug Discovery Today|February 22, 2025
Unlocking disease insights to facilitate drug development: Pharmaceutical industry-academia collaborations in inflammation and immunologyElena Peeva, Emma Guttman-Yassky, Yuji Yamaguchi, et al.
Pageof 80